Rational design of liposomes for sustained release drug delivery of bevacizumab to treat ocular angiogenesis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Drug Delivery Science and Technology"
DOI: 10.1016/j.jddst.2018.07.003
Abstract: Abstract Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD) are the most common ocular diseases and a leading cause of blindness in American adults. Laser treatments and drug intervention with Ranibizumab, Aflibercept and Bevacizumab are… read more here.
Keywords: drug; drug delivery; treat ocular; ocular angiogenesis ... See more keywords